Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Prostate Cancer:

Prevention of Prostate Cancer Morbidity and Mortality: Primary Prevention and Early Detection. Barry MJ et al. Med Clin North Am. (2017)

Prostate cancer. Castillejos-Molina RA et al. Salud Publica Mex. (2016)

Prostate cancer: measuring PSA. Pezaro C et al. Intern Med J. (2014)

Search results

Items: 1 to 20 of 159128

1.

Diagnostic performance of 18F-choline PET-CT in prostate cancer.

Samper Ots P, Luis Cardo A, Vallejo Ocaña C, Cabeza Rodríguez MA, Glaria Enríquez LA, Couselo Paniagua ML, Olivera Vegas J.

Clin Transl Oncol. 2018 Nov 17. doi: 10.1007/s12094-018-1985-2. [Epub ahead of print]

PMID:
30448957
2.

A case of bilateral emphysematous pyelonephritis caused by Candida albicans.

Ideguchi S, Yamamoto K, Ikeda A, Hashimoto K, Takazono T, Saijo T, Imamura Y, Miyazaki T, Mukae H.

J Infect Chemother. 2018 Nov 15. pii: S1341-321X(18)30421-5. doi: 10.1016/j.jiac.2018.10.011. [Epub ahead of print]

PMID:
30448360
3.

Results From a Large, Multicenter, Retrospective Analysis On Radium223 Use in Metastatic Castration-resistant Prostate Cancer (mCRPC) in the Triveneto Italian Region.

Maruzzo M, Basso U, Borsatti E, Evangelista L, Alongi F, Caffo O, Maines F, Galuppo S, De Vivo R, Zustovich F, Palleschi D, Zivi A, Sava T, Sorarù M, Iacovelli R, Nicodemo M, Baier S, Fratino L, Zagonel V.

Clin Genitourin Cancer. 2018 Oct 26. pii: S1558-7673(18)30559-7. doi: 10.1016/j.clgc.2018.10.013. [Epub ahead of print]

PMID:
30448106
4.

Independent knowledge-based treatment planning QA to audit Pinnacle autoplanning.

Janssen TM, Kusters M, Wang Y, Wortel G, Monshouwer R, Damen E, Petit SF.

Radiother Oncol. 2018 Nov 14. pii: S0167-8140(18)33576-X. doi: 10.1016/j.radonc.2018.10.035. [Epub ahead of print]

PMID:
30448001
5.

Effect of long term aspirin use on the incidence of prostate cancer: A systematic review and meta-analysis.

Sauer CM, Myran DT, Costentin CE, Zwisler G, Safder T, Papatheodorou S, Mucci LA.

Crit Rev Oncol Hematol. 2018 Dec;132:66-75. doi: 10.1016/j.critrevonc.2018.09.013. Epub 2018 Sep 29. Review.

PMID:
30447928
6.

The prognostic value of the systemic inflammatory response in randomised clinical trials in cancer: A systematic review.

Dolan RD, Laird BJA, Horgan PG, McMillan DC.

Crit Rev Oncol Hematol. 2018 Dec;132:130-137. doi: 10.1016/j.critrevonc.2018.09.016. Epub 2018 Oct 5. Review.

PMID:
30447918
7.

Re: [177Lu]-PSMA-617 Radionuclide Treatment in Patients with Metastatic Castration-resistant Prostate Cancer (LuPSMA Trial): A Single-centre, Single-arm, Phase 2 Study.

De Man K, Ost P.

Eur Urol. 2018 Nov 14. pii: S0302-2838(18)30859-5. doi: 10.1016/j.eururo.2018.11.005. [Epub ahead of print] No abstract available.

PMID:
30447887
8.

Urologic Pathology: Key Parameters from a Urologist's Perspective.

Borchert A, Rogers CG.

Surg Pathol Clin. 2018 Dec;11(4):893-901. doi: 10.1016/j.path.2018.07.012. Epub 2018 Oct 17. Review.

PMID:
30447847
9.

Genitourinary Pathology Reporting Parameters Most Relevant to the Medical Oncologist.

Hwang C.

Surg Pathol Clin. 2018 Dec;11(4):877-891. doi: 10.1016/j.path.2018.07.009. Epub 2018 Oct 17. Review.

PMID:
30447846
10.

Updates on Grading and Staging of Prostate Cancer.

Braunhut BL, Punnen S, Kryvenko ON.

Surg Pathol Clin. 2018 Dec;11(4):759-774. doi: 10.1016/j.path.2018.07.003. Review.

PMID:
30447840
11.

Large-Gland Proliferations of the Prostate.

Iczkowski KA.

Surg Pathol Clin. 2018 Dec;11(4):687-712. doi: 10.1016/j.path.2018.07.001. Epub 2018 Oct 17. Review.

PMID:
30447836
12.

Dual responsive micelles capable of modulating miRNA-34a to combat taxane resistance in prostate cancer.

Lin F, Wen D, Wang X, Mahato RI.

Biomaterials. 2018 Nov 3;192:95-108. doi: 10.1016/j.biomaterials.2018.10.036. [Epub ahead of print]

PMID:
30447399
13.

'Just as I expected': A longitudinal cohort study of the impact of response expectancies on side effect experiences during radiotherapy for prostate cancer.

Devlin EJ, Whitford HS, Denson LA, Potter AE.

J Pain Symptom Manage. 2018 Nov 14. pii: S0885-3924(18)31063-7. doi: 10.1016/j.jpainsymman.2018.11.002. [Epub ahead of print]

PMID:
30447387
14.

Evaluation of Tumour Coverage after MR-Guided Prostate Focal Laser Ablation Therapy.

Knull E, Oto A, Eggener S, Tessier D, Guneyli S, Chatterjee A, Fenster A.

Med Phys. 2018 Nov 17. doi: 10.1002/mp.13292. [Epub ahead of print]

PMID:
30447155
15.

Association Between the Interleukin-17 Gene Polymorphism -197G>A and the Risk of Prostate Cancer in a Galician Population.

Aguín N, Rodríguez-Alonso A, López-Trigo N, Castuera IP, Luis JR, Caeiro B.

Pathol Oncol Res. 2018 Nov 16. doi: 10.1007/s12253-018-0537-y. [Epub ahead of print]

PMID:
30446888
16.

Real-World Use and Outcomes of Olaparib: a Population-Based Cohort Study.

Eriksson I, Wettermark B, Bergfeldt K.

Target Oncol. 2018 Nov 16. doi: 10.1007/s11523-018-0604-z. [Epub ahead of print]

PMID:
30446872
17.

[Partial gland ablation with vascular-targeted phototherapy versus active surveillance for low-risk prostate cancer : Results of a randomized trial].

Salomon G.

Urologe A. 2018 Nov 16. doi: 10.1007/s00120-018-0809-x. [Epub ahead of print] German. No abstract available.

PMID:
30446781
18.

Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer.

Liu C, Lou W, Yang JC, Liu L, Armstrong CM, Lombard AP, Zhao R, Noel ODV, Tepper CG, Chen HW, Dall'Era M, Evans CP, Gao AC.

Nat Commun. 2018 Nov 16;9(1):4700. doi: 10.1038/s41467-018-07178-x.

PMID:
30446660
19.

AKT inhibition modulates H3K4 demethylase levels in PTEN null prostate cancer.

Khan MI, Hamid A, Rath S, Ateeq B, Khan Q, Siddiqui IA, Adhami VM, Choudhry H, Zamzami MA, Mukhtar H.

Mol Cancer Ther. 2018 Nov 16. pii: molcanther.0141.2018. doi: 10.1158/1535-7163.MCT-18-0141. [Epub ahead of print]

PMID:
30446585
20.

Impact of metabolic syndrome on oncologic outcomes at radical prostatectomy.

Morlacco A, Moro FD, Rangel LJ, Carlson RE, Schulte PJ, Jeffrey KR.

Urol Oncol. 2018 Nov 13. pii: S1078-1439(18)30384-3. doi: 10.1016/j.urolonc.2018.10.003. [Epub ahead of print]

PMID:
30446466

Supplemental Content

Loading ...
Support Center